• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15931 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox — Allergan Inc.) indication: chronic migraine
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro — UCB Canada Inc.) indication: idiopathic parkinson disease (early and advanced)
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra — Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of new versus refurbished surgical tables: comparative clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with osteoarthritis: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation prior to surgery: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention of dehydration in geriatric patients in long-term care: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of endotracheal tubes with subglottic secretion drainage to prevent ventilator-associated pneumonia: clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) SmartSite bag access device: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Computer-assisted interpretation of electrocardiograms: diagnostic accuracy and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous infusion pumps for transfusion of blood products: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for seniors in the community setting: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques and products for surgical hand antisepsis: a review of guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Off-label use of 5HT3 antagonists: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulized Lidocaine for patients with nasal trauma: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ankle braces for the prevention of injury in sport: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ketorolac for pain management: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Cystoscopy for the diagnosis of patients with urological issues: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for chronic hepatitis C genotype 1
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Obesity interventions delivered in primary care for patients with diabetes: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-free regimens for genotype 1 chronic hepatitis C: a review of the clinical evidence and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for schizophrenia: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Patient-controlled analgesia for pediatric surgical or cancer patients: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protective equipment for antibiotic resistant organisms in rehabilitation facilities: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for tinnitus: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Automated notification and reminder call systems: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Administration of naloxone in a home or community setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure for acute respiratory failure in the pre-hospital setting: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term 5HT3 antagonist use for alcohol dependence: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of massive blood transfusion in the rural setting: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Cryotherapy systems for wart removal: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Jewellery and the risk of bacteria transmission from healthcare worker to patient: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intranasal versus intravenous naloxone for opioid overdose in the pre-hospital setting: comparative clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intrathecal bupivacaine via infusion pump for the management of pain: clinical evidence, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Electromagnetic interference between healthcare laser systems and sensitive electronic devices: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Radiation emissions from computed tomography: a review of the risk of cancer and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Therapeutic recreation for elderly and mental health patients: clinical benefit, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Emergency medical service "treat and release" protocols: a review of clinical and cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous fat grafting for reconstructive surgery: a review of the clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Periodic dental examinations for oral health: a review of clinical effectiveness, cost effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal wireless device use for wound care consultation: a review of safety, clinical benefits and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mattresses for chronic back or neck pain: a review of the clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Stepwise approach for the prescription of opiates for non-cancer pain: a review of clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-aortic balloon pumps for cardiac conditions: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Delivery of electroconvulsive therapy in non-hospital settings: a review of the safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Lifestyle prescriptions: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Home isolation to prevent tuberculosis transmission: a review of the clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Equipment required for medication nebulization: safety and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mobile apps for improving health: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-manual techniques for room disinfection in healthcare facilities: a review of clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Contact investigations following patient and staff exposure to active tuberculosis infections: a review of the clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Closed Intensive Care Units: Clinical and Cost-Effectiveness, Safety, and Guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014 HAYES, Inc. Applied behavior analysis-based interventions for autism spectrum disorder
2014 HAYES, Inc. Artificial disc replacement for cervical degenerative disc disease
2014 HAYES, Inc. Choline PET and PET-CT for suspected recurrent prostate cancer
2014 HAYES, Inc. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014 HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2014 HAYES, Inc. Electrical spinal cord stimulation for the treatment of intractable angina pectoris